Harrow- 8.625% NT REDEEM 30/04/2026 USD 25 Other Current Assets

As of the most recent data (June 2026), HROWL shows a other current assets of $9.9M. That compares with $11M in the prior-year period — down 12.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HROWL's other current assets is now $9.9M (was $11M) — a 12.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Harrow- 8.625% NT REDEEM 30/04/2026 USD 25 is outperforming or lagging.

Tracking HROWL's other current assets over time shows whether Harrow- 8.625% NT REDEEM 30/04/2026 USD 25 is scaling, shrinking, or reshaping that part of the business. The current reading is $9.9M That compares with $11M in the prior-year period — down 12.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Harrow- 8.625% NT REDEEM 30/04/2026 USD 25's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $9.9M) with ownership activity and broader fundamentals.

Harrow- 8.625% NT REDEEM 30/04/2026 USD 25's other current assets is $9.9M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.